Definitive Healthcare (NASDAQ:DH) Posts Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Definitive Healthcare (NASDAQ:DH - Get Free Report) posted its earnings results on Thursday. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.07 by ($0.04), Zacks reports. The firm had revenue of $62.29 million during the quarter, compared to the consensus estimate of $60.60 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. Definitive Healthcare updated its FY 2025 guidance to 0.190-0.220 EPS and its Q1 2025 guidance to 0.020-0.020 EPS.

Definitive Healthcare Stock Down 12.4 %

NASDAQ DH traded down $0.40 during trading on Monday, reaching $2.83. 1,413,851 shares of the company's stock traded hands, compared to its average volume of 945,893. Definitive Healthcare has a 12-month low of $2.58 and a 12-month high of $9.11. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The firm has a market cap of $326.93 million, a price-to-earnings ratio of -0.91, a price-to-earnings-growth ratio of 4.06 and a beta of 1.45. The company's 50 day simple moving average is $4.63 and its two-hundred day simple moving average is $4.48.

Insiders Place Their Bets

In other news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the transaction, the insider now directly owns 433,830 shares of the company's stock, valued at $2,039,001. The trade was a 9.40 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 14.84% of the stock is owned by insiders.

Remove Ads

Wall Street Analysts Forecast Growth

A number of analysts have commented on the company. Barclays reduced their price target on Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating for the company in a research report on Monday. Stephens began coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They issued an "equal weight" rating and a $5.00 price objective for the company. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Two analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $5.61.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.